Clinical Trial Details


Back to Clinical Trials Database

A randomized phase III study of chemotherapy and radiotherapy versus radiotherapy alone as adjuvant treatment to patients with node positive stages Ib or IIa cervix cancer (EO ORTC/NSGO/COSA/MRC intergroup trial)

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 15-Dec-1997
Date Step1 close: 22-Dec-1999
Data management at EORTC Yes
Design Phase 3
Randomized open
Targeted Sample size EORTC Groups: 700
Study Staff
Type of cancer
Participating groups EORTC Gynecological Cancer Group
Nordic Society of Gynecological Oncology
Clinical Oncology Society of Australia
Participating centers
Protocol summary
NCT number NCT00003209